Logo image
How Biologics Have Changed the Drug Discovery Landscape
Journal article   Peer reviewed

How Biologics Have Changed the Drug Discovery Landscape

Paul McGonigle
Annual review of pharmacology and toxicology, v 65(1), pp 29-46
10 Oct 2024
PMID: 39389098
url
https://doi.org/10.1146/annurev-pharmtox-061724-080811View
Published, Version of Record (VoR) Open

Abstract

Animals Artificial Intelligence Biological Products - pharmacology Biological Products - therapeutic use Drug Development - methods Drug Discovery - methods Humans
Advances in molecular biology and molecular genetics as well as major scientific breakthroughs in immunology and oncology have led to the rapid growth of biologic therapeutics. Their success has resulted in significant changes to virtually every step in the drug discovery and development process. Biologics are produced by living organisms, and screening libraries are generated by immunization or phage display. Lead optimization utilizes sophisticated protein engineering to improve drug-like properties and targeting specificity. The manufacturing process for biologics is complex and requires highly specialized facilities. Determination of pharmacology and safety must overcome the complications associated with species specificity. Initial clinical testing must proceed more slowly and carefully due to the limited predictive utility of preclinical data. In summary, the drug discovery and development process has been dramatically altered by biologic therapeutics and will continue to evolve with the introduction of messenger RNA-based therapeutics and the application of artificial intelligence.

Metrics

17 Record Views
4 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pharmacology & Pharmacy
Toxicology
Logo image